Pancreaticoduodenectomy with Extended Retroperitoneal Lymphadenectomy for Periampullary Adenocarcinoma
Authors:
- Charles J. YeoCYCharles J. Yeo
- 1 January 2007
- journal article
- review article
- Published by Elsevier in Surgical Oncology Clinics of North America
- Vol. 16 (1) , 157-176
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trialThe Lancet, 2001
- Resected adenocarcinoma of the pancreas—616 patients: results, outcomes, and prognostic indicatorsJournal of Gastrointestinal Surgery, 2000
- Periampullary AdenocarcinomaAnnals of Surgery, 1998
- DNA content and other factors associated with ten-year survival after resection of pancreatic carcinomaJournal of Surgical Oncology, 1998
- Prediction of recurrence and survival by post-resection CA 19-9 values in patients with adenocarcinoma of the pancreasAnnals of Surgical Oncology, 1997
- Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: Postoperative Adjuvant Chemoradiation Improves SurvivalAnnals of Surgery, 1997
- Significance of lymph node metastases in patients with pancreatic cancer undergoing curative resectionThe American Journal of Surgery, 1996
- CholangiocarcinomaAnnals of Surgery, 1996
- Long-Term Survival After Curative Resection for Pancreatic Ductal AdenocarcinomaAnnals of Surgery, 1996
- Prognostic indicators for survival after resection of pancreatic adenocarcinomaThe American Journal of Surgery, 1993